Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Gyre Therapeutics (GYRE) Tax Rate (2022 - 2025)

Historic Tax Rate for Gyre Therapeutics (GYRE) over the last 8 years, with Q3 2025 value amounting to 22.19%.

  • Gyre Therapeutics' Tax Rate fell 51400.0% to 22.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 29.21%, marking a year-over-year increase of 377500.0%. This contributed to the annual value of 27.23% for FY2024, which is 393800.0% up from last year.
  • Gyre Therapeutics' Tax Rate amounted to 22.19% in Q3 2025, which was down 51400.0% from 29.58% recorded in Q2 2025.
  • Over the past 5 years, Gyre Therapeutics' Tax Rate peaked at 156.09% during Q4 2024, and registered a low of 26.26% during Q4 2022.
  • Moreover, its 4-year median value for Tax Rate was 26.07% (2024), whereas its average is 31.11%.
  • The largest annual percentage gain for Gyre Therapeutics' Tax Rate in the last 5 years was 1576200bps (2024), contrasted with its biggest fall of -123500bps (2024).
  • Gyre Therapeutics' Tax Rate (Quarter) stood at 26.26% in 2022, then soared by 94bps to 1.53% in 2023, then soared by 10310bps to 156.09% in 2024, then plummeted by -86bps to 22.19% in 2025.
  • Its last three reported values are 22.19% in Q3 2025, 29.58% for Q2 2025, and 19.44% during Q1 2025.